Insider Sale: Colgate-Palmolive (NYSE:CL) Insider Sells 48,778 Shares

Colgate-Palmolive (NYSE:CL – Get Rating) insider Prabha Parameswaran sold 48,778 shares of the company in a trade on Monday, August 29. The stock was sold at an average price of $78.80, for a total value of $3,843,706.40. Following the completion of the transaction, the insider now owns 6,787 shares of the company, valued at $534,815.60. The transaction was disclosed in a document filed with the SEC, which is available via this hyperlink.

Colgate-Palmolive stock down 1.0%

CL stock traded at $0.79 on Wednesday, hitting $78.21. 4,002,371 shares of the company were traded, against an average volume of 5,021,174. Colgate-Palmolive has a 12-month low of $72.20 and a 12-month high of $85.61. The stock has a market capitalization of $65.24 billion, a P/E ratio of 34.20, a price-to-earnings growth ratio of 5.70 and a beta of 0.48. The company has a debt ratio of 14.26, a quick ratio of 0.72 and a current ratio of 1.17. The company has a 50-day moving average price of $79.76 and a two-hundred-day moving average price of $78.16.

Colgate-Palmolive (NYSE:CL – Get Rating) last reported results on Friday, July 29. The company reported earnings per share of $0.72 for the quarter, beating the consensus estimate of $0.71 by $0.01. The company posted revenue of $4.48 billion for the quarter, versus a consensus estimate of $4.35 billion. Colgate-Palmolive achieved a net margin of 10.98% and a return on equity of 315.10%. Colgate-Palmolive revenue increased 5.3% compared to the same quarter last year. In the same quarter of the previous year, the company achieved EPS of $0.80. As a group, equity research analysts expect Colgate-Palmolive to post 3.03 EPS for the current fiscal year.

Colgate-Palmolive dividend announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 15. Shareholders of record on Thursday, July 21 received a dividend of $0.47. This represents an annualized dividend of $1.88 and a dividend yield of 2.40%. The ex-dividend date was Wednesday, July 20. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 81.39%.

Colgate-Palmolive Institutional Trading

Several large investors have recently changed their positions in the company. TCI Wealth Advisors Inc. increased its stake in Colgate-Palmolive shares by 76.0% in the second quarter. TCI Wealth Advisors Inc. now owns 315 shares of the company worth $25,000 after buying 136 more shares in the last quarter. Better Money Decisions LLC purchased a new stake in Colgate-Palmolive in Q2 worth approximately $25,000. Core Alternative Capital strengthened its position in Colgate-Palmolive by 924.3% in the 1st quarter. Core Alternative Capital now owns 379 shares of the company worth $29,000 after buying 342 additional shares in the last quarter. Verity Asset Management Inc. acquired a new stake in Colgate-Palmolive in Q1 worth approximately $29,000. Finally, Horan Securities Inc. purchased a new stake in Colgate-Palmolive during the fourth quarter for $30,000. 78.62% of the shares are held by hedge funds and other institutional investors.

Wall Street analysts predict growth

CL has been the subject of several analyst reports. JPMorgan Chase & Co. lowered its price target on Colgate-Palmolive shares from $79.00 to $78.00 in a Thursday, July 21 research note. Deutsche Bank Aktiengesellschaft lowered its price target on Colgate-Palmolive from $88.00 to $87.00 in a Tuesday, July 19 research report. Wells Fargo & Company raised Colgate-Palmolive to an “equal weight” rating in a Tuesday, Aug. 9 research report. UBS Group raised its price target on Colgate-Palmolive from $88.00 to $90.00 and gave the stock a “buy” rating in a Monday, Aug. 1, report. Finally, StockNews.com upgraded Colgate-Palmolive from a “hold” rating to a “buy” rating in a Tuesday, August 2, report. Twelve equity research analysts have rated the stock with a hold rating and four have assigned the stock a buy rating. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $84.57.

About Colgate Palmolive

(Get a rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The Company operates through two segments, Oral, Personal and Home Care; and animal nutrition. The Oral, Personal and Home Care segment offers toothpastes, toothbrushes, mouthwashes, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin care products, dishwashing detergents, fabric conditioners, household cleaners and other related items.

Featured articles

Insider buying and selling by quarter for Colgate-Palmolive (NYSE:CL)

This instant alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]

Before you consider Colgate-Palmolive, you’ll want to hear this.

MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Colgate-Palmolive wasn’t on the list.

While Colgate-Palmolive currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

See the five actions here

About Patrick K. Moon

Check Also

The best-selling books of the week

Reading room The best-selling New Zealand books of the week, as recorded by the Nielsen …